InnovationRx: The FDA OKs The First RSV Vaccine; Microsoft’s AI Play For Doctors by TheAlexKnapp, katiedjennings
Microsoft Wants To Automate Medical Notes With GPT-4— But Doctors Need Convincing
ILLUSTRATION BY YUNJIA YUAN FOR FORBES; GETTY IMAGES/DNY59; GETTY IMAGES/SUBJUG; GETTY IMAGES/NENOV; GETTY IMAGES/THAMRONGPAT THEERATHAMMAKORN An app called the Dragon Ambient eXperience, or DAX, records doctor’s interactions with patients and uses artificial intelligence to generate notes for the medical record. It was developed by Nuance Communications, Microsoft’s $19 billion bet on the future of AI in healthcare. So far there has been a human quality reviewer checking the AI’s work before it's sent to the doctor for a final review.
in Kindbody. The startup, which has raised $315 million, operates 32 fertility clinics and offers reproductive health benefits for large employers, including Walmart and Medtronic.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
FDA OKs Once-Nightly Sodium Oxybate for NarcolepsyExtended-release sodium oxybate (Lumryz) is taken once at bedtime for the treatment of cataplexy or excessive daytime sleepiness in adults with narcolepsy.
Lire la suite »
LA City Council OKs Mayor Bass’s 3 harbor commission appointmentsFormer U.S. Rep. Lucille Roybal-Allard, Michael Muñoz and Lee Williams were confirmed to the harbor commission.
Lire la suite »
FAA OKs New, More Direct Routes - Videos from The Weather ChannelThe FAA has activated over 150 new shorter routes along the East Coast. Your next flight just might be shorter than you expected. - Videos from The Weather Channel | weather.com
Lire la suite »
Santa Clara council OKs transitional housing project for homeless familiesThe Santa Clara City Council voted 4-3, with some councilmembers wanting the county to explore more permanent housing.
Lire la suite »
FDA Fast Tracks Potential CAR T-Cell Therapy for LupusThe cellular therapy depletes CD19-positive B cells with the goal of 'resetting' the immune system to achieve durable remission.
Lire la suite »
Xelstrym to Launch Soon: New FDA-Approved ADHD Stimulant PatchXelstrym is the first FDA-approved transdermal amphetamine patch to treat pediatric and adult patients with ADHD. It is expected to launch later this year.
Lire la suite »